¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary complex"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • primary aqueous
    ÀÏÂ÷¹æ¼ö, ¿ø¹æ¼ö
  • primary atelectasis
    ¿ø¹ß¹«±âÆó
  • primary atypical pneumonia
    ¿ø¹ßºñÁ¤ÇüÆó·Å
  • primary biliary cirrhosis
    ¿ø¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
  • primary bronchus
    ÀÏÂ÷±â°üÁö
  • primary cancer
    ¿ø¹ß¾Ï
  • primary carcinoma
    ¿ø¹ß¾ÏÁ¾
  • primary cardiomyopathy
    ¿ø¹ß½ÉÀå±ÙÀ°º´(Áõ), ¿ø¹ß½É±Ùº´(Áõ)
  • primary cement
    ÀÏÂ÷½Ã¸àÆ®Áú
  • primary character
    ÀÏÂ÷¼º°Ý
  • primary cholestatic liver disease
    ¿ø¹ß¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ¿ø¹ß´ãÁóÁ¤Ã¼°£Áúȯ
  • primary ciliary dyskinesia
    ¿ø¹ß¼¶¸ð¿îµ¿ÀÌ»óÁõ
  • primary contact
    ÀÏÂ÷Á¢ÃË
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary culture
    óÀ½½É±â
  • primary biliary cirrhosis
    ¿ø¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • primary health care
    ÀÏÂ÷º¸°ÇÀÇ·á
  • primary ossification center
    ÀÏÂ÷»ÀµÇ±âÁß½É, ÀÏÂ÷°ñÈ­Áß½É
  • primary sex character
    ÀÏÂ÷¼ºÂ¡
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary dentin
    ÀÏÂ÷»ó¾ÆÁú
  • primary dentition
    (¢¡deciduous tooth) Á¥´Ï, Å»¶ôÄ¡¾Æ
  • primary depression
    ÀÏÂ÷¿ì¿ïÁõ
  • primary dysmenorrhea
    ¿ø¹ß¿ù°æÅë
  • primary ciliary dyskinesia
    ¿ø¹ß¼¶¸ð¿îµ¿ÀÌ»óÁõ
  • primary degenerative dementia
    ÀÏÂ÷ÅðÇàÄ¡¸Å
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • primary epilepsy
    ¿ø¹ß°£Áú, ÀÏÂ÷°£Áú
  • primary fissure
    ù°ƴ»õ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary amenorrhea
    ¿ø¹ß¼º ¹«¿ù°æ(ê«Û¡àõÙíêÅÌè), 1Â÷¼º ¹«¿ù°æ
  • primary amenorrhea
    ¿ø¹ß(¼º) ¹«¿ù°æ(ê«Û¡(àõ) ÙíêÅÌè)
  • primary amine
    ÀÏÂ÷¾Æ¹Î.
  • primary amnion
    ÀÏÂ÷¾ç¸·
  • primary amnion
    ¿ø½Ã¾ç¸·
  • primary amyloidosis
    ¿ø¹ß(¼º) ¾Æ¹Ð·Î À̵åÁõ.
  • primary amyloidosis
    ¿ø¹ß(¼º)(ê«Û¡(àõ)) ¾Æ¹Ð·Î À̵åÁõ
  • primary angle-closure glaucoma
    ¿ø¹ßÆó¼â°¢³ì³»Àå
  • primary antibody response
    ÀÏÂ÷Ç×ü¹ÝÀÀ
  • primary aqueous
    ¿ø¹æ¼ö, ÀÏÂ÷¹æ¼ö
  • primary battery
    ÀÏÂ÷ÀüÁö(ìéó­ï³ò®).
  • primary battery
    ÀÏÂ÷ÀüÁö(ìéó­ï³ò®)
  • primary biliary cirrhosis
    ¿ø¹ß¼º ´ãÁó¼º °£°æº¯(Áõ)
  • primary biliary cirrhosis
    ¿ø¹ß(¼º) ´ãÁó¼º °£°æº¯(Áõ)(ê«Û¡(àõ) ÓÅñðàõ ÊÜÌãܨ(ñø))
  • primary biological productivity
    ÀÏÂ÷»ý¹°»ý»ê·Â(¡­ßæÚªßæß§æ³).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • golgi complex
    °ñÁöº¹ÇÕü
  • hla complex
    HLA À¯ÀüÀÚ±º
  • human leukocyte antigen (HLA) complex
    »ç¶÷ ¹éÇ÷±¸Ç׿øº¹ÇÕü
  • human leukocyte antigen (HLA) complex gene
    »ç¶÷ ¹éÇõ±¸Ç׿øº¹ÇÕü À¯ÀüÀÚ
  • human leukocyte antigen(hla) complex
    ÀÎü¹éÇ÷±¸Ç׿øº¹ÇÕü(ìÑô÷ÛÜúìϹù÷ê«ÜÜùêô÷)
  • human leukocyte antigen(hla) complex,class i
    1±º
  • human leukocyte antigen(hla) complex,class ii
    2±º
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • immune complex
    ¸é¿ªº¹ÇÕü
  • immune complex
    ¸é¿ªº¹ÇÕü.
  • immune complex disease
    ¸é¿ªº¹ÇÕüº´.
  • immune complex measurement
    ¸é¿ªº¹ÇÕÃ¼ÃøÁ¤
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³ °ú¹Î¹ÝÀÀ
  • immune complex urticaria
    ¸é¿ªº¹Çյε巯±â
  • immune complex vasculitis
    ¸é¿ªº¹ÇÕüÇ÷°ü¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • enzyme-inhibitor complex
    È¿¼Ò-ÀúÇØÁ¦ º¹ÇÕü (ý£áÈîÁúªð¥ÜÜùêô÷)
  • enzyme-substrate complex
    È¿¼Ò-±âÁú º¹ÇÕü (ý£áÈÐñòõÜÜùêô÷)
  • H-2 complex
    H-2 º¹ÇÕü(ÜÜùêô÷)
  • immune complex
    ¸é¿ª º¹ÇÕü(Øóæ¹ÜÜùêô÷)
  • initiation complex
    °³½Ãº¹ÇÕ¹°(ËÒã·ÜÜùêÚª)
  • junctional complex
    Á¢ÇպΠº¹ÇÕü(ïÈùêÝ»ÜÜùêô÷)
  • low spin complex
    Àú(î¸)½ºÇÉ º¹ÇÕ¹°(ÜÜùêÚª)
  • major histocompatibility complex
    ÁÖ Á¶Á÷ÀûÇÕ º¹ÇÕü(ñ«ðÚòÄîêùêÜÜùêô÷)
  • major immunogene complex
    ÁÖ ¸é¿ªÀ¯ÀüÀÚ º¹ÇÕü(ñ«Øóæµë¶îîí­ÜÜùêô÷)
  • metal bridge complex
    ±Ý¼Ó(ÐÝáÕ) ´Ù¸® º¹ÇÕü(ÜÜùêô÷)
  • Michaelis complex
    ¹ÌŰ¿¤¸®½º º¹ÇÕ¹°(ÜÜùêÚª)
  • mixed complex
    È¥¼ºº¹ÇÕ¹°(ûèà÷ÜÜùêÚª)
  • mononuclear complex
    ´ÜÇÙº¹ÇÕ¹°(Ó¤ú·ÜÜùêÚª)
  • multienzyme complex
    ´ÙÈ¿¼Òº¹ÇÕ¹°(Òýý£áÈÜÜùêÚª)
  • NADH-dehydrogenase complex
    NADH-µðÇÏÀ̵å·ÎÀú³×À̽º º¹ÇÕü(ÜÜùêô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PDHC Pyruvate De-Hydrogenase Complex
SCC   1) Sude Chain-Cleavage Complex
  2) Squamous Cell Carcinoma
ADC adult day care [facility]; affective disorders clinic; Aid to [Families with] Dependent Children; AI...
Ag-Ab antigen-antibody complex
ALC absolute lymphocyte count; acute lethal catatonia; aided living center; Alternative Lifestyle Checkl...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PRIME-MD Primary Care Evaluation of Mental Disorders
PCG Primary Care Group
PCP Primary Care Physician
PCT Primary Care Team
PCNSL Primary Central Nervous System Lymphoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary afferent nociceptor input
    ÀÏÂ÷ ±¸½É¼º Ä§ÇØ¼ö¿ëü ÀÔ·Â, ÀÏÂ÷ ±¸½É¼º À¯Çؼö¿ë±â ÀÔ·Â
  • primary afferent projection
    ÀÏÂ÷ ±¸½É¼º Åõ»ç
  • primary afferent terminal
    ÀÏÂ÷ ±¸½É¼º ¸»´Ü
  • primary amenorrhea
    ¿ø¹ß ¹«¿ù°æ, ¿ø¹ß¼º ¹«¿ù°æ
  • primary amyloidosis
    ¿ø¹ß¼º À¯ÀüºÐÁõ, ¿ø¹ß ¾Æ¹Ð·ÎÀ̵åÁõ, ¿ø¹ß¼º ¾Æ¹Ð·ÎÀ̵åÁõ
  • primary anesthesia
    ÀÏÂ÷ ¸¶Ãë
  • primary benign leukoplakias
    ¿ø¹ß¼º ¾ç¼º ¹é¹ÝÁõ
  • primary bond
    ÀÏÂ÷ °áÇÕ
    ÀϹÝÀûÀ¸·Î À̿ °áÇÕ, °øÀ¯ °áÇÕ, ¹èÀ§ °áÇÕ, ±Ý¼Ó °áÇÕ µîÀ» ¸»ÇÏ¸ç °áÇÕ·ÂÀÌ °¡Àå °­ÇÏ´Ù
  • primary bullous dermatoses
    ¿ø¹ß ¼öÆ÷¼º ÇǺκ´
  • primary carcinoma
    ¿ø¹ß ¾ÏÁ¾
  • primary cement
    ÀÏÂ÷ ½Ã¸àÆ®Áú, Á¦ÀÏ ½Ã¸àÆ®Áú
  • primary cephalic vein
    ÀÏÂ÷ ¸Ó¸® Á¤¸Æ
  • primary closure
    ÀÏÂ÷ ºÀÇÕ
  • primary color
    ¿ø»ö, ±âº»»ö
    µ¿ÀǾî=fundamental color. È¥ÇÕ¿¡ ÀÇÇØ¼­ ´Ù¸¥ »ö±òÀ» ¸¸µå´Âµ¥ ÀÌ¿ëµÇ´Â 3°¡Áö ±âº»»öÀ¸·Î ºûÀÇ ºÎ°¡ÀûÀΠȥÇÕÀ̳ª Âø»öÁ¦¸¦ »« °ÍÀÌ´Ù.
  • primary colors subtractive
    °¨»ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
platelet glycoprotein gpib-ix complex Platelet membrane glycoprotein complex essential for normal platelet adhesion and clot formation at sites of vascular injury. It is composed of three polypeptides, gpib alpha, gpib beta, and gpix. Glycoprotein ib functions as a receptor for von willebrand factor and for thrombin. Congenital deficiency of the gpib-ix complex results in bernard-soulier syndrome. The platelet glycoprotein gpv associates with gpib-ix and is also absent in bernard-soulier syndrome.
(12 Dec 1998)
platelet glycoprotein gpiib-iiia complex Platelet membrane glycoprotein complex important for platelet adhesion and aggregation. The complex is an integrin which recognises the arginine-glycine-aspartic acid (rgd) sequence present on several adhesive proteins. As such, it is a receptor for fibrinogen, von willebrand factor, fibronectin, vitronectin, and thrombospondin. A deficiency of gpiib-iiia results in glanzmann's thrombasthenia.
(12 Dec 1998)
multienzyme complex Cluster of distinct enzymes catalysing consecutive reactions of a metabolic pathway, that remain physically associated through purification procedures. Multifunctional enzymes, found in eukaryotes, are a somewhat different phenomenon, since the several enzymic activities are associated with different domains of a single polypeptide.
(18 Nov 1997)
mycobacterium avium complex A serious opportunistic infection caused by two similar bacteria (Mycobacterium avium and Mycobacterium intercellulare) found in the soil and dust particles. In AIDS, MAC can spread through the bloodstream to infect lymph nodes, bone marrow, liver, spleen, spinal fluid, lungs and intestinal tract. Typical symptoms of MAC include night sweats, weight loss, fever, fatigue, diarrhoea and enlarged spleen. MAC is usually found in people with CD4 counts below 100. MAC is also called MAI.
(09 Oct 1997)
mycobacterium avium complex disease <infectious disease> A disease process caused by infection by the organism Mycobacterium avium intracellulare. Almost unheard of in a patient with a normal functioning immune system, this can be a common infection in those with advanced HIV infection.
(27 Sep 1997)
Mycobacterium avium-intracellulare complex An opportunistic agent of people with AIDS. Difficult to treat because Mycobacterium is resistant to many antibiotics. May also cause chronic lower respiratory tract infections.
(05 Mar 2000)
myoelectric complex, migrating Bursts of depolarisation that move from the stomach to the ileocaecal valve at regular frequency during the interdigestive period. The complex and its accompanying motor activity periodically cleanse the bowel of interdigestive secretion and debris in preparation for the next meal.
(12 Dec 1998)
polyvinylpyrrolidone-iodine complex <chemical> A water soluble complex of iodine with polyvinylpyrrolidone. Applied as an antiseptic in the form of solutions or ointments, it releases iodine. Used in cleansing and disinfecting the skin, preparing the skin preoperatively, and treating infections susceptible to iodine.
1-ethenyl-2-pyrrolidone homopolymer complexed with iodine. An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabelled for research purposes.
Synonym: polyvinylpyrrolidone-iodine complex, povidone-iodine.
Pharmacological action: anti-infective agents, local, iodophors.
Chemical name: 2-Pyrrolidinone, 1-ethenyl-, homopolymer, compd. With iodine
(20 Sep 2002)
H-2 complex <immunology> A term that denotes the genes of the mouse equivalent of the human major histocompatibility complex system.
It is a set of genetic loci coding for Class I and Class II major histocompatibility complex antigens and for complement components.
See: histocompatability antigen.
(20 Jun 2000)
histocompatibility complex A family of fifty or more genes on the sixth human chromosome that code for cell surface proteins and play a role in the immune response.Histocompatibility genes control the production of proteins on the outer membranes of tissue and blood cells, especially lymphocytes, and are vital elements in cell-cell recognition. The proteins also determine the level and type of immune response, and may serve other biochemical or immunologic functions. In the case of allografts, it is necessary to determine whether donor and recipient possess compatible sets of proteins (histocompatibility antigens), to minimise the likelihood of rejection. Histocompatibility testing (HLA tissue typing) provides this information.
(05 Mar 2000)
HLA complex <immunology> The major histocompatibility complex in humans.
See: human lymphocyte antigens.
(05 Mar 2000)
pyruvate dehydrogenase complex <enzyme> A complex multienzyme system that catalyses the conversion of (pyruvate + CoA + NAD) to (acetyl CoA + CO2 + NAD).
(18 Nov 1997)
pyruvate dehydrogenase complex deficiency An autosomal recessive pyruvate metabolism disorder resulting from deficient enzyme activity in one of several proteins of pyruvate dehydrogenase complex, resulting in deficiency of acetyl CoA. Deficiency in acetyl CoA product reduces the synthesis of acetylcholine, thereby causing neurological abnormalities. Clinical presentations include lactic acidosis, mental retardation, and ataxia.
(12 Dec 1998)
pyruvate dehydrogenase complex inactivase <enzyme> Pharmacological action: enzyme inhibitor
Registry number: EC 3.4.-
(26 Jun 1999)
S gene complex <molecular biology> Genes coding for molecular components of the pollen stigma recognition system in the cabbage genus Brassica). The gene products govern the self incompatibility response and include a glycoprotein found on the stigma surface and a lectin on the pollen grain surface that binds to the stigma glycoprotein.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á